| scholarly article | Q13442814 |
| P50 | author | Ludmila Pawlikowska | Q32653026 |
| P2093 | author name string | Helen Kim | |
| Hua Su | |||
| William L Young | |||
| Shantel Weinsheimer | |||
| P2860 | cites work | Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily | Q22008597 |
| Complement factor H polymorphism in age-related macular degeneration | Q24553334 | ||
| Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease | Q24645017 | ||
| Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1 | Q28140462 | ||
| Evidence of inflammatory cell involvement in brain arteriovenous malformations | Q41842014 | ||
| Evidence of Endothelial Progenitor Cells in the Human Brain and Spinal Cord Arteriovenous Malformations | Q42095089 | ||
| Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain | Q42456279 | ||
| Roles of matrix metalloproteinases in flow-induced outward vascular remodeling | Q42946596 | ||
| Roles of macrophages in flow-induced outward vascular remodeling | Q43171048 | ||
| Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations | Q43428687 | ||
| Mouse model for hereditary hemorrhagic telangiectasia has a generalized vascular abnormality | Q44385668 | ||
| Gene microarray analysis of human brain arteriovenous malformations | Q44742760 | ||
| Interleukin-6 involvement in brain arteriovenous malformations | Q45140705 | ||
| Matrix metalloproteinase-9 inhibition attenuates vascular endothelial growth factor-induced intracerebral hemorrhage | Q46152432 | ||
| Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations | Q46196822 | ||
| Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations | Q46198969 | ||
| Polymorphisms in transforming growth factor-beta-related genes ALK1 and ENG are associated with sporadic brain arteriovenous malformations | Q46338357 | ||
| Neutrophil depletion decreases VEGF-induced focal angiogenesis in the mature mouse brain | Q46701595 | ||
| MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations | Q46736603 | ||
| Cerebral vascular abnormalities in a murine model of hereditary hemorrhagic telangiectasia | Q48370925 | ||
| A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. | Q48387488 | ||
| Abnormal balance in the angiopoietin-tie2 system in human brain arteriovenous malformations. | Q51352365 | ||
| Association of a polymorphism of the ACVRL1 gene with sporadic arteriovenous malformations of the central nervous system | Q57338150 | ||
| Expression of Angiogenic Factors and Structural Proteins in Central Nervous System Vascular Malformations | Q57816669 | ||
| Pathogenesis of Arteriovenous Malformations in the Absence of Endoglin | Q60205822 | ||
| Gene Expression in Peripheral Blood Differs after Cardioembolic Compared with Large-Vessel Atherosclerotic Stroke: Biomarkers for the Etiology of Ischemic Stroke | Q61911594 | ||
| Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis | Q81277909 | ||
| Arterial-venous endothelial cell fate is related to vascular endothelial growth factor and Notch status during human bone mesenchymal stem cell differentiation | Q81728223 | ||
| BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis | Q28289169 | ||
| Arteriovenous malformations in mice lacking activin receptor-like kinase-1 | Q28513355 | ||
| ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2 | Q28588420 | ||
| Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease | Q30486777 | ||
| Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia | Q30491276 | ||
| Notch1 activation in mice causes arteriovenous malformations phenocopied by ephrinB2 and EphB4 mutants | Q30493962 | ||
| Gene expression signature in peripheral blood detects thoracic aortic aneurysm | Q33302909 | ||
| Concepts and hypotheses: inflammatory hypothesis in the pathogenesis of cerebral cavernous malformations | Q33305195 | ||
| Arteriovenous malformations of the brain in adults | Q33654319 | ||
| Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population | Q33761353 | ||
| The epidemiology of brain arteriovenous malformations. | Q33913705 | ||
| VEGF Induces More Severe Cerebrovascular Dysplasia in Endoglin than in Alk1 Mice | Q33987975 | ||
| Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia | Q34021937 | ||
| EPHB4 gene polymorphisms and risk of intracranial hemorrhage in patients with brain arteriovenous malformations | Q34129223 | ||
| The New York Islands AVM Study: design, study progress, and initial results | Q34190057 | ||
| Racial/Ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients | Q34659159 | ||
| Endothelial Notch signaling is upregulated in human brain arteriovenous malformations and a mouse model of the disease | Q34983916 | ||
| Vascular morphogenesis: tales of two syndromes. | Q35095942 | ||
| Prevalence of adults with brain arteriovenous malformations: a community based study in Scotland using capture-recapture analysis | Q35469988 | ||
| Apolipoprotein E epsilon 2 is associated with new hemorrhage risk in brain arteriovenous malformations | Q36288424 | ||
| Association of tumor necrosis factor-alpha-238G>A and apolipoprotein E2 polymorphisms with intracranial hemorrhage after brain arteriovenous malformation treatment | Q36288454 | ||
| The effect of genetic diversity on angiogenesis. | Q36328140 | ||
| SMAD4 mutations found in unselected HHT patients. | Q36927105 | ||
| Contribution of bone marrow-derived cells associated with brain angiogenesis is primarily through leukocytes and macrophages. | Q37028696 | ||
| Increased tissue perfusion promotes capillary dysplasia in the ALK1-deficient mouse brain following VEGF stimulation. | Q37038713 | ||
| Endoglin in angiogenesis and vascular diseases | Q37088038 | ||
| Common variants in interleukin-1-Beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation | Q37113819 | ||
| Differential gene expression in human cerebrovascular malformations | Q37258927 | ||
| Development of a cerebral microvascular dysplasia model in rodents | Q37344481 | ||
| Genetic considerations relevant to intracranial hemorrhage and brain arteriovenous malformations | Q37344485 | ||
| Notch-1 signalling is activated in brain arteriovenous malformations in humans | Q37472316 | ||
| The role of complement Factor H in age-related macular degeneration: a review. | Q37729464 | ||
| Gene expression profiling of peripheral blood in patients with abdominal aortic aneurysm | Q38510939 | ||
| P921 | main subject | pathogenesis | Q372016 |
| arteriovenous malformation | Q1584110 | ||
| P304 | page(s) | 83-92 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Acta Neurochirurgica. Supplementum | Q15750154 |
| P1476 | title | Brain arteriovenous malformation pathogenesis: a response-to-injury paradigm | |
| P478 | volume | 111 |
| Q35008897 | A genome-wide investigation of copy number variation in patients with sporadic brain arteriovenous malformation |
| Q49197616 | A proposed classification for assessing rupture risk in patients with intracranial arteriovenous malformations |
| Q91224176 | A single-center study on 140 patients with cerebral cavernous malformations: 28 new pathogenic variants and functional characterization of a PDCD10 large deletion |
| Q61449752 | Activin Receptor-Like Kinase 1 Combined With VEGF-A Affects Migration and Proliferation of Endothelial Cells From Sporadic Human Cerebral AVMs |
| Q48239844 | Acute management of brain arteriovenous malformations |
| Q41952518 | Adult mouse venous hypertension model: common carotid artery to external jugular vein anastomosis |
| Q49807146 | Anatomical Variations of Brain Venous Sinuses in Patients with Arteriovenous Malformations: Incidental Finding or Causative Factor? |
| Q91246633 | Arteriovenous Malformations: Congenital or Acquired Lesions? |
| Q36116089 | Bevacizumab attenuates VEGF-induced angiogenesis and vascular malformations in the adult mouse brain |
| Q57813960 | Beyond endothelial cells: Vascular endothelial growth factors in heart, vascular anomalies and placenta |
| Q33843008 | Brain arteriovenous malformation modeling, pathogenesis, and novel therapeutic targets |
| Q30834817 | Case report of a de novo brainstem arteriovenous malformation in an 18-year-old male and review of the literature |
| Q30662375 | Cerebral arteriovenous malformation presenting with polycythemia vera: A case report and literature review |
| Q38013119 | Concurrent intracranial and spinal arteriovenous malformations: Report of two pediatric cases and literature review |
| Q50122774 | De Novo Arteriovenous Malformation in a Pediatric Patient: Case Report and Review of the Literature. |
| Q87641244 | De novo cerebral arteriovenous malformations: is epileptic seizure a potential trigger? |
| Q90764302 | De novo intracranial arteriovenous malformation - a case report and literature review |
| Q34817246 | Distinctive distribution of lymphocytes in unruptured and previously untreated brain arteriovenous malformation |
| Q27300866 | Endothelial expression of TGFβ type II receptor is required to maintain vascular integrity during postnatal development of the central nervous system |
| Q37671796 | Endothelial signaling and the molecular basis of arteriovenous malformation |
| Q91643257 | Expression of osteopontin, matrix metalloproteinase-2 and -9 proteins in vascular instability in brain arteriovenous malformation |
| Q41897456 | Ferumoxytol-enhanced MRI to Image Inflammation within Human Brain Arteriovenous Malformations: A Pilot Investigation. |
| Q36529825 | G Protein-Coupled Receptor 124 (GPR124) Gene Polymorphisms and Risk of Brain Arteriovenous Malformation |
| Q35961421 | Hemangiomas and vascular malformations: current theory and management |
| Q39399875 | Highlights on Cerebral Arteriovenous Malformation Treatment Using Combined Embolization and Stereotactic Radiosurgery: Why Outcomes are Controversial? |
| Q38857023 | Histologic Evidence for Arteriovenous Malformation-Like Vasculature Occurring within an Intracerebral Schwannoma: A Case Report and Review of the Literature |
| Q27009178 | Imaging of small animal peripheral artery disease models: recent advancements and translational potential |
| Q64376193 | Induction of Brain Arteriovenous Malformation Through CRISPR/Cas9-Mediated Somatic Alk1 Gene Mutations in Adult Mice |
| Q37706143 | Induction of brain arteriovenous malformation in the adult mouse |
| Q50300549 | Inflammation and genetic factors in stroke pathogenesis. |
| Q36258054 | Inhibition of pathological brain angiogenesis through systemic delivery of AAV vector expressing soluble FLT1. |
| Q41895984 | Molecular, Cellular, and Genetic Determinants of Sporadic Brain Arteriovenous Malformations |
| Q35092843 | Novel brain arteriovenous malformation mouse models for type 1 hereditary hemorrhagic telangiectasia |
| Q39852529 | Pathogenesis of Brain Arteriovenous Malformations. |
| Q39668577 | Persistent infiltration and pro-inflammatory differentiation of monocytes cause unresolved inflammation in brain arteriovenous malformation |
| Q33684781 | Polymorphisms in ACVRL1 and endoglin genes are not associated with sporadic and HHT-related brain AVMs in Dutch patients |
| Q48644065 | Results for a series of 697 arteriovenous malformations treated by gamma knife: influence of angiographic features on the obliteration rate |
| Q92271765 | Risk factors for hemorrhage of brain arteriovenous malformation |
| Q34459913 | Role of embolization for cerebral arteriovenous malformations |
| Q92400544 | Spontaneous thrombosis in main draining veins of unruptured cerebral arteriovenous malformations: A case report |
| Q40362625 | Superficial middle cerebral vein connection to the cavernous sinus is not infrequent in brain arteriovenous malformations: an argument against their congenital origin? |
| Q48146672 | Susceptibility loci for sporadic brain arteriovenous malformation; a replication study and meta-analysis. |
| Q51730951 | Thalidomide Reduces Hemorrhage of Brain Arteriovenous Malformations in a Mouse Model. |
| Q55035629 | The Use of Transarterial Approaches in Peripheral Arteriovenous Malformations (AVMs). |
| Q52110306 | The relationship of cortical folding and brain arteriovenous malformations. |
| Q46528698 | The roles of endoglin gene in cerebrovascular diseases |
| Q36304260 | Vascular Integrity in the Pathogenesis of Brain Arteriovenous Malformation |
Search more.